Cargando…
Optimizing Pharmacology Studies in Pregnant and Lactating Women Using Lessons From HIV: A Consensus Statement
Information on the extent of drug exposure to mothers and infants during pregnancy and lactation normally becomes available years after regulatory approval of a drug. Clinicians face knowledge gaps on drug selection and dosing in pregnancy and infant exposure during breastfeeding. Physiological chan...
Autores principales: | Eke, Ahizechukwu C., Olagunju, Adeniyi, Momper, Jeremiah, Penazzato, Martina, Abrams, Elaine J., Best, Brookie M., Capparelli, Edmund V., Bekker, Adrie, Belew, Yodit, Kiser, Jennifer J., Struble, Kimberly, Taylor, Graham, Waitt, Catriona, Mirochnick, Mark, Cressey, Tim R., Colbers, Angela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167886/ https://www.ncbi.nlm.nih.gov/pubmed/32930408 http://dx.doi.org/10.1002/cpt.2048 |
Ejemplares similares
-
Innovative Approaches for Pharmacology Studies in Pregnant and Lactating Women: A Viewpoint and Lessons from HIV
por: Eke, Ahizechukwu C., et al.
Publicado: (2020) -
Characterization of Plasma Protein Alterations in Pregnant and Postpartum Individuals Living With HIV to Support Physiologically-Based Pharmacokinetic Model Development
por: Zhao, Sherry, et al.
Publicado: (2021) -
Physiologically‐based pharmacokinetic modeling of remdesivir and its metabolites in pregnant women with COVID‐19
por: Liu, Xiaomei I., et al.
Publicado: (2022) -
A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women
por: Schalkwijk, Stein, et al.
Publicado: (2018) -
Importance of Prospective Studies in Pregnant and Breastfeeding Women Living With Human Immunodeficiency Virus
por: Colbers, Angela, et al.
Publicado: (2019)